Apollo Hospitals Enterprise Ltd

Apollo Hospitals Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Apollo Hospitals Enterprise Ltd

₹ 8,580 0.64%
10 Jun 9:25 a.m.
apollohospitals.com BSE: 508869 NSE: APOLLOHOSP
About

Apollo Hospitals was established in 1983 by Dr. Prathap C Reddy, renowned architect of modern healthcare in India. As the nation’s first corporate hospital, Apollo Hospitals is acclaimed for pioneering the private healthcare revolution in the country.

Apollo Hospitals has emerged as Asia’s foremost integrated healthcare services provider and has a robust presence across the healthcare ecosystem, including Hospitals, Pharmacies,
Primary Care & Diagnostic Clinics and several Retail Health models. [1]

Key Points

Business Segments
1) Healthcare Services (50% in H1 FY26 vs 55% in FY22):[1][2][3]
The company has a capacity of 10,200 beds in 73 hospitals located in India and overseas, out of which 8,767 beds are located in 45 owned hospitals, 643 beds in Day Surgery & Cradles and 790 beds are in 6 hospitals under management through operations and management contracts.

Website BSE NSE
  • Market Cap ₹ 1,23,425 Cr.
  • Current Price ₹ 8,580
  • High / Low ₹ 8,591 / 6,680
  • Stock P/E 82.2
  • Book Value ₹ 693
  • Dividend Yield 0.22 %
  • ROCE 17.6 %
  • ROE 16.1 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company has been maintaining a healthy dividend payout of 18.7%

Cons

  • Stock is trading at 12.3 times its book value

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of Nifty 50 BSE 500 BSE Healthcare BSE 100 BSE 200

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
1,641 1,688 1,866 1,824 1,895 1,937 2,135 2,055 2,075 2,168 2,356 2,364 2,438
1,218 1,271 1,387 1,374 1,444 1,466 1,595 1,543 1,554 1,622 1,763 1,770 1,843
Operating Profit 423 418 479 450 450 471 540 512 521 546 593 594 596
OPM % 26% 25% 26% 25% 24% 24% 25% 25% 25% 25% 25% 25% 24%
43 18 65 52 46 27 121 108 92 32 141 97 90
Interest 61 61 60 61 69 64 65 62 63 59 58 62 63
Depreciation 97 93 93 97 115 103 108 108 130 123 122 127 128
Profit before tax 309 282 391 344 312 332 488 449 420 397 554 502 494
Tax % 26% 24% 25% 24% 24% 24% 24% 24% 21% 23% 24% 24% 23%
227 214 295 263 239 252 370 342 333 307 420 384 382
EPS in Rs 15.78 14.89 20.50 18.28 16.61 17.51 25.71 23.76 23.19 21.34 29.20 26.67 26.60
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
4,543 5,523 6,301 7,183 8,337 9,794 4,654 6,098 6,525 7,274 8,202 9,326
3,862 4,776 5,527 6,348 7,314 8,377 3,938 4,677 4,831 5,476 6,152 6,998
Operating Profit 681 748 774 835 1,022 1,418 715 1,421 1,694 1,798 2,050 2,328
OPM % 15% 14% 12% 12% 12% 14% 15% 23% 26% 25% 25% 25%
28 4 26 7 8 173 137 131 139 180 342 360
Interest 83 134 200 240 268 426 340 244 239 250 254 242
Depreciation 158 200 241 272 300 482 421 363 367 399 449 500
Profit before tax 467 417 359 330 462 682 91 945 1,228 1,329 1,688 1,946
Tax % 26% 20% 21% 29% 35% 31% -15% 30% 12% 24% 23% 23%
347 334 285 233 303 470 105 665 1,085 1,010 1,296 1,493
EPS in Rs 24.91 24.00 20.50 16.76 21.76 33.80 7.30 46.26 75.45 70.28 90.16 103.81
Dividend Payout % 23% 25% 29% 30% 28% 18% 41% 25% 20% 23% 14% 19%
Compounded Sales Growth
10 Years: 5%
5 Years: 15%
3 Years: 13%
TTM: 14%
Compounded Profit Growth
10 Years: 16%
5 Years: 69%
3 Years: 12%
TTM: 21%
Stock Price CAGR
10 Years: 20%
5 Years: 21%
3 Years: 20%
1 Year: 23%
Return on Equity
10 Years: 12%
5 Years: 15%
3 Years: 15%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 70 70 70 70 70 70 72 72 72 72 72 72
Reserves 3,092 3,246 3,509 3,624 3,814 3,919 5,130 6,039 6,853 7,639 8,662 9,891
1,681 2,346 2,757 2,991 3,238 3,160 3,050 2,752 2,520 3,222 3,090 3,190
978 1,176 857 1,127 1,307 2,996 1,478 1,545 1,335 1,472 1,548 1,762
Total Liabilities 5,820 6,838 7,193 7,812 8,428 10,144 9,729 10,408 10,780 12,405 13,372 14,914
2,428 3,061 3,600 3,762 3,970 6,056 5,038 5,121 5,078 6,032 6,348 6,935
CWIP 512 536 328 698 819 227 219 24 96 200 306 302
Investments 713 877 1,064 900 1,085 1,076 2,091 2,059 2,217 2,621 3,911 4,893
2,167 2,364 2,202 2,452 2,554 2,786 2,381 3,204 3,389 3,553 2,807 2,786
Total Assets 5,820 6,838 7,193 7,812 8,428 10,144 9,729 10,408 10,780 12,405 13,372 14,914

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
389 626 632 539 907 1,096 916 1,201 1,224 1,191 1,742 2,059
-681 -910 -804 -378 -776 -264 -781 -504 -588 -835 -1,046 -1,413
332 290 130 -106 -160 -771 -176 -577 -779 -297 -739 -537
Net Cash Flow 40 7 -42 54 -28 62 -41 120 -143 59 -43 109
Free Cash Flow -296 -146 56 21 324 660 722 682 831 572 897 1,019
CFO/OP 71% 102% 94% 79% 104% 95% 127% 91% 91% 85% 103% 109%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 44 36 38 38 40 36 94 49 46 41 36 33
Inventory Days 50 49 48 52 47 50 63 28 19 22 21 22
Days Payable 48 51 43 45 45 51 254 124 124 138 134 144
Cash Conversion Cycle 46 34 44 44 42 35 -96 -46 -59 -76 -77 -89
Working Capital Days 43 25 37 19 3 -0 12 72 73 64 2 34
ROCE % 12% 11% 9% 9% 11% 13% 4% 13% 16% 15% 16% 18%

Insights

In beta
Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2025
Operating Beds
Number

Log in to view insights

Please log in to see hidden values.

Login
Pharmacy Store Count
Number
Average Length of Stay (ALOS)
Days
Average Revenue Per Occupied Bed (ARPOB/ARPP)
INR/Day
Bed Occupancy Rate
%
Inpatient Discharges
Number

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.33% 29.34% 29.34% 28.02% 28.02% 28.02%
47.93% 46.15% 46.25% 45.63% 43.92% 45.37% 45.27% 42.74% 43.49% 44.20% 43.54% 42.62%
17.02% 18.59% 18.87% 19.55% 21.13% 19.94% 19.97% 22.29% 21.34% 21.12% 21.50% 22.76%
0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23% 0.23%
5.49% 5.68% 5.32% 5.26% 5.38% 5.12% 5.21% 5.41% 5.61% 6.43% 6.71% 6.39%
No. of Shareholders 1,20,0301,31,5651,19,5781,30,6641,27,7541,19,2451,27,8021,34,0581,41,0071,60,5561,78,6481,74,610

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls